These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9614909)

  • 1. Detection of RB1 deletions by fluorescence in situ hybridization in malignant hematologic disorders.
    Juneau AL; Kaehler M; Christensen ER; Schad CR; Zinsmeister AR; Lust J; Hanson C; Dewald GW
    Cancer Genet Cytogenet; 1998 Jun; 103(2):117-23. PubMed ID: 9614909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cytogenetic abnormality of chromosome 13q14 in 112 patients with multiple myeloma detected by using LSI-RB1 and LSI-D13S319 probes].
    Li F; Hu LP; An G; Xu Y; Wang YY; Xing LJ; Yi SH; Xie ZQ; Qiu LG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug; 20(4):917-21. PubMed ID: 22931654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorescence in situ hybridization analysis of 25 cases of idiopathic myelofibrosis and two cases of secondary myelofibrosis: monoallelic loss of RB1, D13S319 and D13S25 loci associated with cytogenetic deletion and translocation involving 13q14.
    Sinclair EJ; Forrest EC; Reilly JT; Watmore AE; Potter AM
    Br J Haematol; 2001 May; 113(2):365-8. PubMed ID: 11380400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of standard prognostic factors with the deletion of 13q14 detected by interphase fluorescence in situ hybridization on separated and unseparated bone marrow cells in multiple myeloma].
    Smejkalová J; Vranová V; Oltová A; Kuglík P; Filková H; Heinigová J; Kovárová L; Adam Z; Krejcí M; Pour L; Büchler T; Svobodník A; Vostrejsová S; Kalábová V; Vorlícek J; Penka M; Hájek R
    Cas Lek Cesk; 2005; 144(7):483-8. PubMed ID: 16161543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of retinoblastoma gene copy number in metaphase chromosomes and interphase nuclei by fluorescence in situ hybridization.
    Kallioniemi A; Kallioniemi OP; Waldman FM; Chen LC; Yu LC; Fung YK; Smith HS; Pinkel D; Gray JW
    Cytogenet Cell Genet; 1992; 60(3-4):190-3. PubMed ID: 1354594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular cytogenetic aberrations in patients with multiple myeloma studied by interphase fluorescence in situ hybridization.
    Chen L; Li J; Xu W; Qiu H; Zhu Y; Zhang Y; Duan L; Qian S; Lu H
    Exp Oncol; 2007 Jun; 29(2):116-20. PubMed ID: 17704743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One allele deletion of the RB1 gene in a case of refractory anemia with del(13)(q12q14): a fluorescence in situ hybridization study of the RB1 gene.
    Nagamura F; Takabe T; Takahashi S; Ohno N; Uchimaru K; Ogami K; Iseki T; Tojo A; Asano S
    Cancer Genet Cytogenet; 2003 Oct; 146(1):77-80. PubMed ID: 14499701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion of 13q14 remains an independent adverse prognostic variable in multiple myeloma despite its frequent detection by interphase fluorescence in situ hybridization.
    Zojer N; Königsberg R; Ackermann J; Fritz E; Dallinger S; Krömer E; Kaufmann H; Riedl L; Gisslinger H; Schreiber S; Heinz R; Ludwig H; Huber H; Drach J
    Blood; 2000 Mar; 95(6):1925-30. PubMed ID: 10706856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular cytogenetic analysis in splenic lymphoma with villous lymphocytes: frequent allelic imbalance of the RB1 gene but not the D13S25 locus on chromosome 13q14.
    García-Marco JA; Nouel A; Navarro B; Matutes E; Oscier D; Price CM; Catovsky D
    Cancer Res; 1998 Apr; 58(8):1736-40. PubMed ID: 9563492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletions of chromosome 13q in monoclonal gammopathy of undetermined significance.
    Königsberg R; Ackermann J; Kaufmann H; Zojer N; Urbauer E; Krömer E; Jäger U; Gisslinger H; Schreiber S; Heinz R; Ludwig H; Huber H; Drach J
    Leukemia; 2000 Nov; 14(11):1975-9. PubMed ID: 11069034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent monoallelic loss of D13S319 in multiple myeloma patients shown by interphase fluorescence in situ hybridization.
    Chang H; Bouman D; Boerkoel CF; Stewart AK; Squire JA
    Leukemia; 1999 Jan; 13(1):105-9. PubMed ID: 10049044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytogenetics of multiple myeloma: interpretation of fluorescence in situ hybridization results.
    Harrison CJ; Mazzullo H; Cheung KL; Gerrard G; Jalali GR; Mehta A; Osier DG; Orchard KH
    Br J Haematol; 2003 Mar; 120(6):944-52. PubMed ID: 12648063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A der(13)t(7;13)(p13;q14) with monoallelic loss of RB1 and D13S319 in myelodysplastic syndrome.
    Yamamoto K; Ito M; Minagawa K; Urahama N; Sada A; Okamura A; Matsui T
    Cancer Genet Cytogenet; 2005 Oct; 162(2):160-5. PubMed ID: 16213365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive role of interphase cytogenetics for survival of patients with multiple myeloma.
    Königsberg R; Zojer N; Ackermann J; Krömer E; Kittler H; Fritz E; Kaufmann H; Nösslinger T; Riedl L; Gisslinger H; Jäger U; Simonitsch I; Heinz R; Ludwig H; Huber H; Drach J
    J Clin Oncol; 2000 Feb; 18(4):804-12. PubMed ID: 10673522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic lymphocytic leukemia with del13q14 as the sole abnormality: dynamic prognostic estimate by interphase-FISH.
    Orlandi EM; Bernasconi P; Pascutto C; Giardini I; Cavigliano PM; Boni M; Zibellini S; Cazzola M
    Hematol Oncol; 2013 Sep; 31(3):136-42. PubMed ID: 23060227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delineation of the minimal region of loss at 13q14 in multiple myeloma.
    Elnenaei MO; Hamoudi RA; Swansbury J; Gruszka-Westwood AM; Brito-Babapulle V; Matutes E; Catovsky D
    Genes Chromosomes Cancer; 2003 Jan; 36(1):99-106. PubMed ID: 12461754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Correlation between chromosome 13q14 deletion and 1q abnormality in multiple myeloma].
    Chen LJ; Li JY; Zhu Y; Wang XW; Qiu HR; Yang RF; Xu W; Xu JR; Lu H
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Feb; 26(1):102-5. PubMed ID: 19199264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorescent in situ hybridization studies in multiple myeloma.
    Yuregir OO; Sahin FI; Yilmaz Z; Kizilkilic E; Karakus S; Ozdogu H
    Hematology; 2009 Apr; 14(2):90-4. PubMed ID: 19298720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular cytogenetic aberrations in Tunisian patients with multiple myeloma identified by cIg-FISH in fixed bone marrow cells.
    Gmidène A; Avet-Loiseau H; Sennana H; Ben Abdallah I; Khlif A; Meddeb B; Elloumi M; Saad A
    Cytogenet Genome Res; 2012; 136(1):44-9. PubMed ID: 22188899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurobeachin (NBEA) is a target of recurrent interstitial deletions at 13q13 in patients with MGUS and multiple myeloma.
    O'Neal J; Gao F; Hassan A; Monahan R; Barrios S; Kilimann MW; Lee I; Chng WJ; Vij R; Tomasson MH
    Exp Hematol; 2009 Feb; 37(2):234-44. PubMed ID: 19135901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.